AI's land‑grab era is giving way to hard questions about costs, pricing power, and semiconductor cyclicality. Discover why rising model prices, tighter supply chains, and shifting unit economics may reshape the winners and losers in this space by watching the video below. *This video was published on May 29, 2026. Continue reading
AI's land‑grab era is giving way to hard questions about costs, pricing power, and semiconductor cyclicality. Discover why rising model prices, tighter supply chains, and shifting unit economics may reshape the winners and losers in this space by watching the video below. *This video was published on May 29, 2026. Continue reading
Dmitry Vinogradov Shares of NervGen Pharma ( NGEN ) traded higher on Thursday after TD Cowen initiated the Canadian biotech with a Buy recommendation, assuming $1.1B peak sales for the company’s lead asset NVG-291. The injectable expected to undergo a registrational study in mid-2026 for chronic tetraplegia, a paralysis caused by spinal cord injury, has shown encouraging efficacy results in a Phas...
Dmitry Vinogradov Shares of NervGen Pharma ( NGEN ) traded higher on Thursday after TD Cowen initiated the Canadian biotech with a Buy recommendation, assuming $1.1B peak sales for the company’s lead asset NVG-291. The injectable expected to undergo a registrational study in mid-2026 for chronic tetraplegia, a paralysis caused by spinal cord injury, has shown encouraging efficacy results in a Phase 1/2 trial, said analyst Joseph Thome. “The treatment was safe with high adherence, demonstrating promising activity across biomarker and functional measures,” Thome argued, adding that key opinion leaders are optimistic about the RESTORE registrational study, which is scheduled to complete enrollments in mid-2027. “Given the high unmet need, our KOL believes that such a pharmacologic treatment, if approved, would see rapid uptake and enthusiastic support given the paucity of currently available options,” he wrote. Based on KOL feedback, Thome projected $1.1B peak sales for NVG-291, implying a $12 per-share value on an NPV basis, but stopped short of issuing a price target for the stock. More on NervGen Pharma NervGen Pharma: I See Promise, But The Clock Is Ticking (Rating Downgrade) NervGen Pharma prices 24M share public offering; warrants exercisable at $3.68 NervGen launches underwritten public offering of shares and warrants Seeking Alpha’s Quant Rating on NervGen Pharma Historical earnings data for NervGen Pharma
Roborock’s Q10 S5 Plus comes with a self-emptying dock and is under $300. | Image: Roborock Even at full price, the Roborock Q10 S5 Plus offers impressive value, boasting features typically reserved for pricier robovac models at a fraction of the price. That’s especially true today. It’s down to just $269.99 ($280 off) at Wellbots when you apply promo code NEW10 , which matches its all-time low an...
Roborock’s Q10 S5 Plus comes with a self-emptying dock and is under $300. | Image: Roborock Even at full price, the Roborock Q10 S5 Plus offers impressive value, boasting features typically reserved for pricier robovac models at a fraction of the price. That’s especially true today. It’s down to just $269.99 ($280 off) at Wellbots when you apply promo code NEW10 , which matches its all-time low and is the best price we’ve seen since Black Friday last year. If you prefer a different retailer, you can also buy it at Amazon and directly from Robovac for $10 more. Roborock Q10 S5 Plus Where to Buy: $549.99 $279.99 at Amazon $549.99 $269.99 at Wellbots (with code NEW10) $549.99 $279.99 at Roborock The robovac is one of our top picks if you’re on a budget, with good AI-powered obstacle detection and navigation that helps it clean around clutter without getting stuck. It also boasts automatic carpet detection and a mop that can lift itself over rugs, so you don’t need to worry about carpets getting wet. The flat vibrating mop pad also impressed us in testing and is particularly gentle on delicate floors, able to scrub away dirt effectively without leaving them soaked. When it finishes cleaning, the included dock automatically empties the robovac’s dustbin and recharges the bot, reducing the amount of maintenance required. Of course, there are some compromises Roborock made to keep costs down. Unlike Roborock’s much pricier $1,600 Saros 20, the Q10 S5 Plus can’t climb taller thresholds, and its 10,000Pa suction isn’t nearly as powerful as the Saros’ 36,000Pa system. The dock also lacks conveniences like automatic mop washing and water-tank refilling, meaning you’ll still need to handle those tasks yourself. Still, for under $300, it’s hard to complain given everything else the Q10 S5 Plus brings to the table.
The administration imposed mandatory quarantine orders on two passengers from the cruise ship hit by hantavirus and is blocking Americans who catch Ebola from returning home for treatment. (Image credit: Rebecca S. Gratz)
The administration imposed mandatory quarantine orders on two passengers from the cruise ship hit by hantavirus and is blocking Americans who catch Ebola from returning home for treatment. (Image credit: Rebecca S. Gratz)
Sven Piper/iStock Editorial via Getty Images SpaceX's ( SPCX ) Starlink continues to experience positive mobile growth, but xAI's ( X.AI ) Grok and X face potential headwinds as usage and revenue stagnate in 2026, according to market intelligence firm Sensor Tower. "SpaceX’s +$1tn valuation is setting the company up for the largest IPO in history. Starlink, which accounted for the majority (61%) o...
Sven Piper/iStock Editorial via Getty Images SpaceX's ( SPCX ) Starlink continues to experience positive mobile growth, but xAI's ( X.AI ) Grok and X face potential headwinds as usage and revenue stagnate in 2026, according to market intelligence firm Sensor Tower. "SpaceX’s +$1tn valuation is setting the company up for the largest IPO in history. Starlink, which accounted for the majority (61%) of the company’s revenue in 2025, is continuing to experience strong demand per Sensor Tower estimates. However, falling adoption and usage of Grok and X could signal caution to investors evaluating the prospects of SpaceX's AI business," said analyst Kara Lee. In the quarter-to-date, or QTD, second quarter of 2026, AI chatbot Grok ranks within the top eight generative AI apps by global MAUs (49.7M) and within the top six generative AI apps by global downloads (19M). However, the analysts noted that while Grok has reached a substantial user base since it launched in January 2025, it's experiencing a marginal decline in usage in QTD second quarter of 2026, with Monthly Active Users, or MAUs, falling 5% quarter-over-quarter, or QoQ, versus an average increase of 51% QoQ for OpenAI's ( OPENAI ) ChatGPT, Anthropic's ( ANTHRO ) Claude, and Google's ( GOOG ) ( GOOGL ) Gemini. Similarly, Grok’s downloads are currently down 22% year-over-year, or YoY, in QTD second quarter of 2026 (April-May), and ChatGPT is also experiencing a 13% YoY decline. However, Gemini (+160% YoY) and Claude (+15x YoY) are still seeing rapid app adoption, according to the research firm. The analyst said that Starlink’s global MAUs have experienced consistent growth, up 60%, 56%, and 65% YoY in 2024, 2025, and half-to-date, or HTD, first half of 2026, respectively. Lee added that Starlink’s downloads have grown in parallel with its MAUs, up 84% and 68% in 2024 and 2025, respectively. "As SpaceX positioned for a potential IPO, the company’s US ad spend increased 21x YoY in 1Q26 and is up 800% YoY in QTD 2Q26, ...
Ugly, Tailing 30Y Auction Sees Foreign Demand Tumble, Dealer "Backtop" Bid Jump After yesterday's stellar 10Y auction, which saw the 5th highest Indirect take down on record, today's reopening of $22BN in 30Y paper (via Cusip UU0) was a mirror image: ugly, poor foreign demand, and tailing. Starting at the top, the auction priced at a high yield of 5.02%, down fractionally from 5.046% last month (w...
Ugly, Tailing 30Y Auction Sees Foreign Demand Tumble, Dealer "Backtop" Bid Jump After yesterday's stellar 10Y auction, which saw the 5th highest Indirect take down on record, today's reopening of $22BN in 30Y paper (via Cusip UU0) was a mirror image: ugly, poor foreign demand, and tailing. Starting at the top, the auction priced at a high yield of 5.02%, down fractionally from 5.046% last month (which was the first 5% coupon auction in history). And just like last month, today's auction also tailed the When Issued 5.008% by 1.2bps; this was the third tailing 30y auction and was also the biggest tail since August 2025. Next, we look at the bid to cover which at 2.328 was a bit higher than last month's 2.303, which however was the lowest this year; it means that the BtC was well below the recent average of 2.43. The internals were even uglier: in contrast to yesterday's surge in Indirect demand, today's Indirects took down just 59.95%, down from 66.6% and the lowest since August 2025. And with Directs rising to 25.31%, above the six-auction average of 23.7%, Dealers were left holding 14.74%, or the highest since July 2025. In summary: this was a very ugly, tailing auction, which saw foreign demand tumble, offset by the biggest "backstop" bid from Dealers in almost a year. Whether this was the result of today's red hot PPI, or because investors are allocating capital to SpaceX and have little left to fund US spending, remains to be seen. Tyler Durden Thu, 06/11/2026 - 13:41